PRESS RELEASE Within the context of Sarantis Group’s strategic development, and with the aim to significantly reinforce the dynamics of the Group’s Health & Care division, the Group is including the French Company OENOBIOL in its product portfolio.
ANNOUNCEMENT The company GR. SARANTIS S.A. announces, according to the article 21 of the L.3556/2007 and the article 11 of the Hellenic Capital Market Commission decision 1/434/3.
ANNOUNCEMENT The company GR. SARANTIS S.A. announces, according to the article 21 of the L.3556/2007 and the article 11 of the Hellenic Capital Market Commission decision 1/434/3.
PRESS RELEASE Main Points Sarantis Group’s turnover increased by 13.16% to €173.96 mil. from €153.73 mil. in 9m 2006. Gross profit margin increased to 50.
ANNOUNCEMENT The company GR. SARANTIS S.A. announces, according to the article 21 of the L.3556/2007 and the article 11 of the Hellenic Capital Market Commission decision 1/434/3.
ANNOUNCEMENT The company GR. SARANTIS S.A. announces, according to the article 21 of the L.3556/2007 and the article 11 of the Hellenic Capital Market Commission decision 1/434/3.
PRESS RELEASE Gr. Sarantis SA will release the 9M 2007 consolidated financial results, according to the following schedule: Monday the 19th of November after ASE close – Results Release, which will be available in the Athens Stock Exchange web page (www.
ANNOUNCEMENT The company GR. SARANTIS S.A. announces, according to the article 21 of the L.3556/2007 and the article 11 of the Hellenic Capital Market Commission decision 1/434/3.